HomeKTTA • NASDAQ
Pasithea Therapeutics Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.26M | — |
Net income | -3.18M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.10M | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.92M | -57.61% |
Total assets | 16.06M | -38.49% |
Total liabilities | 1.28M | -52.84% |
Total equity | 14.78M | — |
Shares outstanding | 2.71M | — |
Price to book | 0.11 | — |
Return on assets | -46.96% | — |
Return on capital | -50.00% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.18M | — |
Cash from operations | -2.44M | — |
Cash from investing | — | — |
Cash from financing | -23.55K | — |
Net change in cash | -2.44M | — |
Free cash flow | -1.33M | — |
Previous close
$1.21
Day range
$1.16 - $1.23
Year range
$0.92 - $8.25
Market cap
3.21M USD
Avg Volume
78.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2020
Headquarters
Website
Employees
4
